

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 5.41789660 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.41789660 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.41789660 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.41789660 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 5.41789660 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.41789660 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.95513197 |
| 8 | negative regulation of cell killing (GO:0031342) | 4.95513197 |
| 9 | response to peptidoglycan (GO:0032494) | 4.78056082 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 4.60826159 |
| 11 | positive regulation of interferon-alpha production (GO:0032727) | 4.55279048 |
| 12 | regulation of interferon-alpha production (GO:0032647) | 4.34857870 |
| 13 | response to muramyl dipeptide (GO:0032495) | 4.18613223 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.11013842 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.11013842 |
| 16 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.04722001 |
| 17 | immunoglobulin mediated immune response (GO:0016064) | 4.04708445 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.97049108 |
| 19 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.96746760 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 3.95001964 |
| 21 | detection of other organism (GO:0098543) | 3.93992626 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.91919982 |
| 23 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.89338526 |
| 24 | detection of bacterium (GO:0016045) | 3.86182382 |
| 25 | response to host immune response (GO:0052572) | 3.75740780 |
| 26 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.75740780 |
| 27 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.75248018 |
| 28 | granulocyte activation (GO:0036230) | 3.64688979 |
| 29 | leukocyte aggregation (GO:0070486) | 3.55376644 |
| 30 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.48300474 |
| 31 | response to host (GO:0075136) | 3.48300474 |
| 32 | response to host defenses (GO:0052200) | 3.48300474 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.46977473 |
| 34 | neutrophil activation (GO:0042119) | 3.46965137 |
| 35 | detection of external biotic stimulus (GO:0098581) | 3.44831088 |
| 36 | respiratory burst (GO:0045730) | 3.42883901 |
| 37 | positive regulation of interferon-beta production (GO:0032728) | 3.42360160 |
| 38 | regulation of antigen processing and presentation (GO:0002577) | 3.42311048 |
| 39 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.37588314 |
| 40 | response to type I interferon (GO:0034340) | 3.36313692 |
| 41 | type I interferon signaling pathway (GO:0060337) | 3.35342798 |
| 42 | cellular response to type I interferon (GO:0071357) | 3.35342798 |
| 43 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.29782099 |
| 44 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.27916108 |
| 45 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.26560310 |
| 46 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.23334699 |
| 47 | regulation of chemokine biosynthetic process (GO:0045073) | 3.22507805 |
| 48 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.19476323 |
| 49 | positive regulation of heat generation (GO:0031652) | 3.19413180 |
| 50 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.17928048 |
| 51 | T-helper 1 type immune response (GO:0042088) | 3.16350131 |
| 52 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.10225077 |
| 53 | positive regulation of type 2 immune response (GO:0002830) | 3.09833070 |
| 54 | regulation of T cell tolerance induction (GO:0002664) | 3.08053733 |
| 55 | B cell mediated immunity (GO:0019724) | 3.07228711 |
| 56 | cellular response to virus (GO:0098586) | 3.06904194 |
| 57 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.06522396 |
| 58 | natural killer cell mediated immunity (GO:0002228) | 3.06522396 |
| 59 | detection of biotic stimulus (GO:0009595) | 3.05263977 |
| 60 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.04653411 |
| 61 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.03343020 |
| 62 | negative regulation of T cell mediated immunity (GO:0002710) | 3.02062085 |
| 63 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.00511605 |
| 64 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.00314414 |
| 65 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.99653791 |
| 66 | NIK/NF-kappaB signaling (GO:0038061) | 2.99019542 |
| 67 | positive regulation of antigen processing and presentation (GO:0002579) | 2.96679507 |
| 68 | T cell migration (GO:0072678) | 2.95125711 |
| 69 | myeloid cell activation involved in immune response (GO:0002275) | 2.94052316 |
| 70 | cytokine secretion (GO:0050663) | 2.93403313 |
| 71 | regulation of fever generation (GO:0031620) | 2.92625685 |
| 72 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.92552877 |
| 73 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.92023939 |
| 74 | negative regulation of interleukin-12 production (GO:0032695) | 2.91828186 |
| 75 | regulation of podosome assembly (GO:0071801) | 2.91201502 |
| 76 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.91112056 |
| 77 | regulation of interleukin-12 production (GO:0032655) | 2.90663962 |
| 78 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.90385904 |
| 79 | negative regulation of innate immune response (GO:0045824) | 2.90127375 |
| 80 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.88884352 |
| 81 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.84565585 |
| 82 | defense response to protozoan (GO:0042832) | 2.84453062 |
| 83 | response to interferon-alpha (GO:0035455) | 2.84344173 |
| 84 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.83004911 |
| 85 | B cell receptor signaling pathway (GO:0050853) | 2.81089022 |
| 86 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.80068671 |
| 87 | reactive oxygen species biosynthetic process (GO:1903409) | 2.79801763 |
| 88 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.78202226 |
| 89 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.77662477 |
| 90 | myeloid dendritic cell differentiation (GO:0043011) | 2.77659603 |
| 91 | cellular extravasation (GO:0045123) | 2.77177277 |
| 92 | regulation of tolerance induction (GO:0002643) | 2.76831981 |
| 93 | regulation of mast cell activation (GO:0033003) | 2.76687492 |
| 94 | regulation of hypersensitivity (GO:0002883) | 2.76638179 |
| 95 | positive regulation of mast cell degranulation (GO:0043306) | 2.76373317 |
| 96 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.76373317 |
| 97 | positive regulation of interleukin-17 production (GO:0032740) | 2.75187799 |
| 98 | positive regulation of interleukin-12 production (GO:0032735) | 2.74294462 |
| 99 | I-kappaB phosphorylation (GO:0007252) | 2.74277130 |
| 100 | positive regulation of defense response to virus by host (GO:0002230) | 2.73762301 |
| 101 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.73682625 |
| 102 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.73669622 |
| 103 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.73289934 |
| 104 | positive thymic T cell selection (GO:0045059) | 2.72414056 |
| 105 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.72392961 |
| 106 | leukocyte cell-cell adhesion (GO:0007159) | 2.71383175 |
| 107 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.70376474 |
| 108 | response to protozoan (GO:0001562) | 2.70154039 |
| 109 | regulation of gamma-delta T cell activation (GO:0046643) | 2.70127048 |
| 110 | response to interferon-gamma (GO:0034341) | 2.69930788 |
| 111 | microglial cell activation (GO:0001774) | 2.69439854 |
| 112 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.69329192 |
| 113 | positive regulation of B cell differentiation (GO:0045579) | 2.68843876 |
| 114 | regulation of mast cell degranulation (GO:0043304) | 2.68811897 |
| 115 | negative regulation of interleukin-6 production (GO:0032715) | 2.68672162 |
| 116 | germinal center formation (GO:0002467) | 2.68144325 |
| 117 | myeloid dendritic cell activation (GO:0001773) | 2.66687966 |
| 118 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.66079101 |
| 119 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.65407263 |
| 120 | negative regulation of viral genome replication (GO:0045071) | 2.65156538 |
| 121 | low-density lipoprotein particle clearance (GO:0034383) | 2.64947649 |
| 122 | positive regulation of mast cell activation (GO:0033005) | 2.64928981 |
| 123 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.63885737 |
| 124 | regulation of interferon-beta production (GO:0032648) | 2.63307583 |
| 125 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.61084739 |
| 126 | macrophage activation (GO:0042116) | 2.60857396 |
| 127 | regulation of integrin activation (GO:0033623) | 2.60295814 |
| 128 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.59920152 |
| 129 | superoxide anion generation (GO:0042554) | 2.59539944 |
| 130 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.59235034 |
| 131 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.56970774 |
| 132 | positive regulation of chemokine production (GO:0032722) | 2.56663676 |
| 133 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.56144919 |
| 134 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.56063033 |
| 135 | cellular response to interferon-beta (GO:0035458) | 2.55838615 |
| 136 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.55738068 |
| 137 | detection of molecule of bacterial origin (GO:0032490) | 2.55187662 |
| 138 | cellular response to interferon-gamma (GO:0071346) | 2.54921086 |
| 139 | regulation of cholesterol storage (GO:0010885) | 2.54742272 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.25260882 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.77239637 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.55813677 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.15585828 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.46325001 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.31284406 |
| 7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.21374872 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.17589585 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.09361758 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.96561027 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.96320192 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.87984839 |
| 13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.87030458 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.69190794 |
| 15 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.66660972 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.56627003 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.46393356 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.45344827 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.27678622 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.23187463 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.14406644 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.08753390 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.05669562 |
| 24 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.05401980 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.01037775 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 1.86169401 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.78977745 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.78624980 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.77550432 |
| 30 | * MYC_22102868_ChIP-Seq_BL_Human | 1.77475373 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 1.67872110 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.63853396 |
| 33 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.62061846 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.61044474 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.57855092 |
| 36 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.56049834 |
| 37 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.54163741 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 1.51854944 |
| 39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50293250 |
| 40 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.49551872 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48033474 |
| 42 | UTX_26944678_Chip-Seq_JUKART_Human | 1.44796883 |
| 43 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.44668924 |
| 44 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.43815319 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.41611399 |
| 46 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.41446315 |
| 47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40358363 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.40103078 |
| 49 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.38484324 |
| 50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37462234 |
| 51 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.35916524 |
| 52 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35035614 |
| 53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34638879 |
| 54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31966609 |
| 55 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.30559198 |
| 56 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.28356945 |
| 57 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.27969109 |
| 58 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.25659786 |
| 59 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.25324682 |
| 60 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25166684 |
| 61 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.23686351 |
| 62 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22733140 |
| 63 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22597776 |
| 64 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.22417462 |
| 65 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.20771945 |
| 66 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.20567957 |
| 67 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.20567957 |
| 68 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.17849049 |
| 69 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.16923521 |
| 70 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16057990 |
| 71 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.15073300 |
| 72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14882249 |
| 73 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13422242 |
| 74 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13317336 |
| 75 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11368855 |
| 76 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.10522724 |
| 77 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.10509274 |
| 78 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09958412 |
| 79 | MAF_26560356_Chip-Seq_TH2_Human | 1.09860805 |
| 80 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.09637600 |
| 81 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09437611 |
| 82 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09017670 |
| 83 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.08558131 |
| 84 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.06787633 |
| 85 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06648701 |
| 86 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04390013 |
| 87 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03299628 |
| 88 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02478602 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02152316 |
| 90 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.02105059 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02086421 |
| 92 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01535470 |
| 93 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00618914 |
| 94 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99930673 |
| 95 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99685226 |
| 96 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99424986 |
| 97 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.97977936 |
| 98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.97486343 |
| 99 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97054461 |
| 100 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96754786 |
| 101 | P68_20966046_ChIP-Seq_HELA_Human | 0.96636150 |
| 102 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96309395 |
| 103 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96267924 |
| 104 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95965140 |
| 105 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94738207 |
| 106 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.94622944 |
| 107 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.92789976 |
| 108 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.92639104 |
| 109 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.92506013 |
| 110 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92037099 |
| 111 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91645073 |
| 112 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91441083 |
| 113 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.91286655 |
| 114 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.90813138 |
| 115 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.90361708 |
| 116 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90151079 |
| 117 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.89023012 |
| 118 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.88192839 |
| 119 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88149696 |
| 120 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.87594515 |
| 121 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.87242992 |
| 122 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86226925 |
| 123 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.85905527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.47666263 |
| 2 | MP0003303_peritoneal_inflammation | 3.44732107 |
| 3 | MP0003436_decreased_susceptibility_to | 3.40606618 |
| 4 | MP0009785_altered_susceptibility_to | 3.18214918 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 2.68056754 |
| 6 | MP0005000_abnormal_immune_tolerance | 2.63119655 |
| 7 | MP0001790_abnormal_immune_system | 2.61349403 |
| 8 | MP0005387_immune_system_phenotype | 2.61349403 |
| 9 | MP0002419_abnormal_innate_immunity | 2.56020557 |
| 10 | MP0000685_abnormal_immune_system | 2.55299658 |
| 11 | MP0005025_abnormal_response_to | 2.52489167 |
| 12 | MP0004947_skin_inflammation | 2.49349861 |
| 13 | MP0001800_abnormal_humoral_immune | 2.35298716 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.32316712 |
| 15 | MP0003724_increased_susceptibility_to | 2.26358748 |
| 16 | MP0004510_myositis | 2.23943929 |
| 17 | MP0009278_abnormal_bone_marrow | 2.22377052 |
| 18 | MP0006082_CNS_inflammation | 2.18454178 |
| 19 | MP0002723_abnormal_immune_serum | 2.15355149 |
| 20 | MP0003300_gastrointestinal_ulcer | 1.94377400 |
| 21 | MP0001819_abnormal_immune_cell | 1.93071763 |
| 22 | MP0002420_abnormal_adaptive_immunity | 1.90571216 |
| 23 | MP0001853_heart_inflammation | 1.88773301 |
| 24 | MP0005671_abnormal_response_to | 1.87311196 |
| 25 | MP0002006_tumorigenesis | 1.84270770 |
| 26 | MP0003448_altered_tumor_morphology | 1.78274974 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.76609163 |
| 28 | MP0002405_respiratory_system_inflammati | 1.75449059 |
| 29 | MP0009764_decreased_sensitivity_to | 1.75129079 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.74430600 |
| 31 | MP0005076_abnormal_cell_differentiation | 1.74230677 |
| 32 | MP0003566_abnormal_cell_adhesion | 1.72749543 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.70292681 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.70292681 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.69888261 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.69707743 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.68483891 |
| 38 | MP0003453_abnormal_keratinocyte_physiol | 1.68209634 |
| 39 | MP0000858_altered_metastatic_potential | 1.66999320 |
| 40 | MP0010352_gastrointestinal_tract_polyps | 1.64262670 |
| 41 | MP0002254_reproductive_system_inflammat | 1.62604999 |
| 42 | MP0009840_abnormal_foam_cell | 1.58267779 |
| 43 | MP0000343_altered_response_to | 1.52549290 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.52007123 |
| 45 | MP0002398_abnormal_bone_marrow | 1.48154575 |
| 46 | MP0002166_altered_tumor_susceptibility | 1.47992842 |
| 47 | MP0000716_abnormal_immune_system | 1.45160110 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 1.44905134 |
| 49 | MP0008469_abnormal_protein_level | 1.44459763 |
| 50 | MP0003191_abnormal_cellular_cholesterol | 1.44019396 |
| 51 | MP0005167_abnormal_blood-brain_barrier | 1.41290168 |
| 52 | MP0010307_abnormal_tumor_latency | 1.38907420 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.32485371 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.30093585 |
| 55 | MP0010234_abnormal_vibrissa_follicle | 1.23969211 |
| 56 | MP0005023_abnormal_wound_healing | 1.23691343 |
| 57 | MP0002722_abnormal_immune_system | 1.23458995 |
| 58 | MP0002429_abnormal_blood_cell | 1.20729690 |
| 59 | MP0003828_pulmonary_edema | 1.17336731 |
| 60 | MP0003172_abnormal_lysosome_physiology | 1.15235784 |
| 61 | MP0004782_abnormal_surfactant_physiolog | 1.11934386 |
| 62 | MP0003075_altered_response_to | 1.11010253 |
| 63 | MP0005166_decreased_susceptibility_to | 1.08245550 |
| 64 | MP0008004_abnormal_stomach_pH | 1.07781793 |
| 65 | MP0003690_abnormal_glial_cell | 1.07174315 |
| 66 | MP0003866_abnormal_defecation | 1.06949799 |
| 67 | MP0001873_stomach_inflammation | 1.05752123 |
| 68 | MP0002998_abnormal_bone_remodeling | 1.04983694 |
| 69 | MP0002796_impaired_skin_barrier | 1.04103044 |
| 70 | MP0003806_abnormal_nucleotide_metabolis | 1.04092615 |
| 71 | MP0005310_abnormal_salivary_gland | 1.04014052 |
| 72 | MP0001216_abnormal_epidermal_layer | 1.03446783 |
| 73 | MP0003763_abnormal_thymus_physiology | 1.01637855 |
| 74 | MP0004808_abnormal_hematopoietic_stem | 1.00462253 |
| 75 | MP0003195_calcinosis | 1.00326846 |
| 76 | MP0002332_abnormal_exercise_endurance | 0.99789821 |
| 77 | MP0004883_abnormal_blood_vessel | 0.99759249 |
| 78 | MP0009763_increased_sensitivity_to | 0.95985109 |
| 79 | MP0001851_eye_inflammation | 0.95014858 |
| 80 | MP0002138_abnormal_hepatobiliary_system | 0.93593965 |
| 81 | MP0003091_abnormal_cell_migration | 0.93313479 |
| 82 | MP0005390_skeleton_phenotype | 0.90823974 |
| 83 | MP0001663_abnormal_digestive_system | 0.90583686 |
| 84 | MP0000490_abnormal_crypts_of | 0.90166331 |
| 85 | MP0000604_amyloidosis | 0.88762608 |
| 86 | MP0002139_abnormal_hepatobiliary_system | 0.86749486 |
| 87 | MP0002060_abnormal_skin_morphology | 0.84078829 |
| 88 | MP0002933_joint_inflammation | 0.82711301 |
| 89 | MP0000465_gastrointestinal_hemorrhage | 0.81622589 |
| 90 | MP0005164_abnormal_response_to | 0.78074813 |
| 91 | MP0004381_abnormal_hair_follicle | 0.77163040 |
| 92 | MP0005083_abnormal_biliary_tract | 0.76513420 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.75455527 |
| 94 | MP0005451_abnormal_body_composition | 0.75435058 |
| 95 | MP0000703_abnormal_thymus_morphology | 0.74563467 |
| 96 | MP0000249_abnormal_blood_vessel | 0.74464162 |
| 97 | MP0009931_abnormal_skin_appearance | 0.74365467 |
| 98 | MP0002277_abnormal_respiratory_mucosa | 0.74188711 |
| 99 | MP0000767_abnormal_smooth_muscle | 0.73655734 |
| 100 | MP0005501_abnormal_skin_physiology | 0.73259436 |
| 101 | MP0001191_abnormal_skin_condition | 0.72479428 |
| 102 | MP0002132_abnormal_respiratory_system | 0.71577421 |
| 103 | MP0000609_abnormal_liver_physiology | 0.68439535 |
| 104 | MP0003186_abnormal_redox_activity | 0.68247921 |
| 105 | MP0005275_abnormal_skin_tensile | 0.68182220 |
| 106 | MP0002019_abnormal_tumor_incidence | 0.68116521 |
| 107 | MP0001986_abnormal_taste_sensitivity | 0.67983347 |
| 108 | MP0003045_fibrosis | 0.67835412 |
| 109 | MP0002098_abnormal_vibrissa_morphology | 0.66989545 |
| 110 | MP0002396_abnormal_hematopoietic_system | 0.66313563 |
| 111 | MP0008260_abnormal_autophagy | 0.66034647 |
| 112 | MP0000569_abnormal_digit_pigmentation | 0.65921869 |
| 113 | MP0001958_emphysema | 0.65815852 |
| 114 | MP0003656_abnormal_erythrocyte_physiolo | 0.65332847 |
| 115 | MP0009765_abnormal_xenobiotic_induced | 0.65012395 |
| 116 | MP0003795_abnormal_bone_structure | 0.64206866 |
| 117 | MP0008874_decreased_physiological_sensi | 0.63084690 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.58704351 |
| 119 | MP0003646_muscle_fatigue | 0.58608772 |
| 120 | MP0000015_abnormal_ear_pigmentation | 0.58225259 |
| 121 | MP0005319_abnormal_enzyme/_coenzyme | 0.53158114 |
| 122 | MP0005381_digestive/alimentary_phenotyp | 0.51325774 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.03387685 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.92393007 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.42801215 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.66855364 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.31881540 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.10681942 |
| 7 | Autoimmune thrombocytopenia (HP:0001973) | 4.06603767 |
| 8 | * Mediastinal lymphadenopathy (HP:0100721) | 3.91044563 |
| 9 | Myositis (HP:0100614) | 3.83544912 |
| 10 | Stomatitis (HP:0010280) | 3.76713580 |
| 11 | Orchitis (HP:0100796) | 3.75193115 |
| 12 | Interstitial pulmonary disease (HP:0006530) | 3.71159046 |
| 13 | Pustule (HP:0200039) | 3.53443198 |
| 14 | Gingivitis (HP:0000230) | 3.50647046 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.44712769 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.36171923 |
| 17 | Cellulitis (HP:0100658) | 3.32242364 |
| 18 | Recurrent skin infections (HP:0001581) | 3.29343978 |
| 19 | Vasculitis (HP:0002633) | 3.28640621 |
| 20 | Dysostosis multiplex (HP:0000943) | 3.18465772 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 3.16409495 |
| 22 | Optic neuritis (HP:0100653) | 3.16409495 |
| 23 | Recurrent viral infections (HP:0004429) | 3.14996326 |
| 24 | Encephalitis (HP:0002383) | 3.08475678 |
| 25 | Vacuolated lymphocytes (HP:0001922) | 3.07209522 |
| 26 | Periodontitis (HP:0000704) | 3.06055536 |
| 27 | Increased cerebral lipofuscin (HP:0011813) | 2.99974876 |
| 28 | Systemic lupus erythematosus (HP:0002725) | 2.99092307 |
| 29 | Hematochezia (HP:0002573) | 2.95439885 |
| 30 | Chronic otitis media (HP:0000389) | 2.93269486 |
| 31 | Urticaria (HP:0001025) | 2.85050473 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 2.79013422 |
| 33 | Obstructive lung disease (HP:0006536) | 2.79013422 |
| 34 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.73773364 |
| 35 | Thick nail (HP:0001805) | 2.72666674 |
| 36 | Myocardial infarction (HP:0001658) | 2.72433302 |
| 37 | T lymphocytopenia (HP:0005403) | 2.69075525 |
| 38 | Nasal polyposis (HP:0100582) | 2.68666844 |
| 39 | Abnormality of the nasal mucosa (HP:0000433) | 2.67653014 |
| 40 | Panhypogammaglobulinemia (HP:0003139) | 2.65393597 |
| 41 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.65292169 |
| 42 | Tetraparesis (HP:0002273) | 2.60186098 |
| 43 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.60059570 |
| 44 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.60059570 |
| 45 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.60059570 |
| 46 | Increased IgE level (HP:0003212) | 2.58590007 |
| 47 | Abnormality of T cell number (HP:0011839) | 2.56666744 |
| 48 | Osteomyelitis (HP:0002754) | 2.55293896 |
| 49 | Premature loss of primary teeth (HP:0006323) | 2.46288710 |
| 50 | Axonal loss (HP:0003447) | 2.46256195 |
| 51 | Pulmonary infiltrates (HP:0002113) | 2.41297712 |
| 52 | Mucopolysacchariduria (HP:0008155) | 2.40481290 |
| 53 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.40481290 |
| 54 | Colitis (HP:0002583) | 2.38653015 |
| 55 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.38027769 |
| 56 | Osteolytic defects of the hand bones (HP:0009699) | 2.38027769 |
| 57 | Chest pain (HP:0100749) | 2.38025529 |
| 58 | Meningitis (HP:0001287) | 2.37793211 |
| 59 | Basal ganglia calcification (HP:0002135) | 2.36332410 |
| 60 | Pulmonary embolism (HP:0002204) | 2.32887921 |
| 61 | Arterial thrombosis (HP:0004420) | 2.32578591 |
| 62 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.30485153 |
| 63 | Recurrent cutaneous fungal infections (HP:0011370) | 2.30485153 |
| 64 | Malnutrition (HP:0004395) | 2.28943283 |
| 65 | Skin ulcer (HP:0200042) | 2.28901078 |
| 66 | Episodic fever (HP:0001954) | 2.27878333 |
| 67 | Abnormality of T cells (HP:0002843) | 2.27875799 |
| 68 | Mutism (HP:0002300) | 2.27829439 |
| 69 | Purpura (HP:0000979) | 2.27346055 |
| 70 | Spontaneous hematomas (HP:0007420) | 2.27213196 |
| 71 | Emphysema (HP:0002097) | 2.26819376 |
| 72 | Leukocytosis (HP:0001974) | 2.25329826 |
| 73 | Prolonged bleeding time (HP:0003010) | 2.24318176 |
| 74 | Recurrent bronchitis (HP:0002837) | 2.23045051 |
| 75 | Abnormality of the pleura (HP:0002103) | 2.22688383 |
| 76 | Recurrent pneumonia (HP:0006532) | 2.21784198 |
| 77 | Gingival bleeding (HP:0000225) | 2.21564363 |
| 78 | Gastrointestinal stroma tumor (HP:0100723) | 2.15182003 |
| 79 | Hypergammaglobulinemia (HP:0010702) | 2.14880790 |
| 80 | Disinhibition (HP:0000734) | 2.14725846 |
| 81 | Nephritis (HP:0000123) | 2.13799044 |
| 82 | Esophageal varix (HP:0002040) | 2.13340712 |
| 83 | Inflammation of the large intestine (HP:0002037) | 2.13080064 |
| 84 | Increased IgM level (HP:0003496) | 2.12531636 |
| 85 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.08593685 |
| 86 | Keratoconjunctivitis sicca (HP:0001097) | 2.07714296 |
| 87 | Abnormality of the endocardium (HP:0004306) | 2.06240527 |
| 88 | Increased serum ferritin (HP:0003281) | 2.06179968 |
| 89 | Gastrointestinal inflammation (HP:0004386) | 2.05753143 |
| 90 | Hemoptysis (HP:0002105) | 2.03347717 |
| 91 | Polyneuropathy (HP:0001271) | 2.03008467 |
| 92 | Granulocytopenia (HP:0001913) | 2.01321660 |
| 93 | Recurrent lower respiratory tract infections (HP:0002783) | 2.01072043 |
| 94 | Glomerulonephritis (HP:0000099) | 2.00998909 |
| 95 | Peritonitis (HP:0002586) | 1.99144996 |
| 96 | Neuronal loss in central nervous system (HP:0002529) | 1.96845900 |
| 97 | Prostate neoplasm (HP:0100787) | 1.95294341 |
| 98 | Bone pain (HP:0002653) | 1.95281373 |
| 99 | Gastrointestinal infarctions (HP:0005244) | 1.95130087 |
| 100 | Glomerulopathy (HP:0100820) | 1.94739394 |
| 101 | Acne (HP:0001061) | 1.94116521 |
| 102 | Complement deficiency (HP:0004431) | 1.92527277 |
| 103 | Keratoconjunctivitis (HP:0001096) | 1.91035104 |
| 104 | Restrictive lung disease (HP:0002091) | 1.88803797 |
| 105 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.85578306 |
| 106 | Petechiae (HP:0000967) | 1.85537584 |
| 107 | Loss of speech (HP:0002371) | 1.85298256 |
| 108 | Lymphopenia (HP:0001888) | 1.82934006 |
| 109 | Sepsis (HP:0100806) | 1.82353850 |
| 110 | Arthralgia (HP:0002829) | 1.81218385 |
| 111 | Abnormality of the pericardium (HP:0001697) | 1.81107982 |
| 112 | Abnormality of iron homeostasis (HP:0011031) | 1.81090329 |
| 113 | Porencephaly (HP:0002132) | 1.80806844 |
| 114 | Epistaxis (HP:0000421) | 1.80381244 |
| 115 | Abnormality of the fingertips (HP:0001211) | 1.80125128 |
| 116 | Pathologic fracture (HP:0002756) | 1.79055242 |
| 117 | Amyloidosis (HP:0011034) | 1.78961989 |
| 118 | Cheilitis (HP:0100825) | 1.78097448 |
| 119 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.76867199 |
| 120 | Abnormality of glycolipid metabolism (HP:0010969) | 1.76867199 |
| 121 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.76867199 |
| 122 | Anorexia (HP:0002039) | 1.75650338 |
| 123 | Joint hemorrhage (HP:0005261) | 1.74191530 |
| 124 | Hypochromic anemia (HP:0001931) | 1.71909966 |
| 125 | Vertebral compression fractures (HP:0002953) | 1.71754140 |
| 126 | Gangrene (HP:0100758) | 1.71689722 |
| 127 | Agammaglobulinemia (HP:0004432) | 1.71431128 |
| 128 | Autoimmune hemolytic anemia (HP:0001890) | 1.71411139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.99170593 |
| 2 | MAP4K1 | 3.13877390 |
| 3 | ERN1 | 3.08813836 |
| 4 | TBK1 | 3.08130202 |
| 5 | TYK2 | 2.81394732 |
| 6 | BLK | 2.67668668 |
| 7 | IRAK3 | 2.61770363 |
| 8 | IKBKE | 2.54410146 |
| 9 | RIPK4 | 2.42833934 |
| 10 | IRAK4 | 2.29867640 |
| 11 | JAK3 | 2.27859488 |
| 12 | IKBKB | 2.11690556 |
| 13 | CDK12 | 2.05173906 |
| 14 | PRPF4B | 2.01306039 |
| 15 | MAP3K10 | 1.95434862 |
| 16 | STK10 | 1.87382311 |
| 17 | CHUK | 1.83566690 |
| 18 | KIT | 1.82956363 |
| 19 | EPHB1 | 1.82162118 |
| 20 | TNK2 | 1.78507310 |
| 21 | PIM2 | 1.75670976 |
| 22 | JAK1 | 1.72573872 |
| 23 | CSK | 1.64520726 |
| 24 | CDC42BPA | 1.58672751 |
| 25 | RIPK1 | 1.57728314 |
| 26 | GRK7 | 1.53797041 |
| 27 | FES | 1.52675898 |
| 28 | PIM1 | 1.52611776 |
| 29 | ZAP70 | 1.50389630 |
| 30 | MARK3 | 1.47690421 |
| 31 | TAOK2 | 1.45373662 |
| 32 | TGFBR2 | 1.41905202 |
| 33 | MAP3K3 | 1.41366584 |
| 34 | TXK | 1.38893631 |
| 35 | MST4 | 1.34094620 |
| 36 | FGFR4 | 1.32467066 |
| 37 | RPS6KA4 | 1.30687724 |
| 38 | TRIB3 | 1.30584792 |
| 39 | LRRK2 | 1.27401646 |
| 40 | BTK | 1.23843632 |
| 41 | BMX | 1.22235836 |
| 42 | MAP3K13 | 1.21437257 |
| 43 | TTN | 1.21218793 |
| 44 | TAOK3 | 1.17892677 |
| 45 | HCK | 1.15160852 |
| 46 | PTK6 | 1.14141728 |
| 47 | MST1R | 1.13604822 |
| 48 | EPHA2 | 1.10230560 |
| 49 | MAP2K3 | 1.04977636 |
| 50 | SYK | 1.04597629 |
| 51 | CSF1R | 1.03384979 |
| 52 | JAK2 | 1.00825836 |
| 53 | TESK2 | 1.00128284 |
| 54 | MATK | 0.99557298 |
| 55 | FGFR3 | 0.96371498 |
| 56 | GRK6 | 0.94921076 |
| 57 | MAP3K11 | 0.94594148 |
| 58 | IRAK1 | 0.93513387 |
| 59 | PRKD2 | 0.91571149 |
| 60 | PBK | 0.91048791 |
| 61 | TRPM7 | 0.87856998 |
| 62 | FGR | 0.86313237 |
| 63 | BMPR2 | 0.85144602 |
| 64 | LCK | 0.83844395 |
| 65 | STK4 | 0.83307044 |
| 66 | NME2 | 0.82535614 |
| 67 | PDK1 | 0.82090703 |
| 68 | MOS | 0.80251867 |
| 69 | ADRBK2 | 0.79811192 |
| 70 | EPHA3 | 0.79439183 |
| 71 | CDK6 | 0.78971413 |
| 72 | LYN | 0.78686884 |
| 73 | MARK2 | 0.76424466 |
| 74 | TEC | 0.76382891 |
| 75 | PKN2 | 0.74762177 |
| 76 | IRAK2 | 0.74734265 |
| 77 | PAK4 | 0.74102012 |
| 78 | FLT3 | 0.73866403 |
| 79 | EEF2K | 0.72991352 |
| 80 | PDPK1 | 0.70789747 |
| 81 | HIPK2 | 0.70515125 |
| 82 | MAP3K5 | 0.67519581 |
| 83 | EIF2AK2 | 0.67195626 |
| 84 | SIK1 | 0.66988387 |
| 85 | DDR2 | 0.66742292 |
| 86 | MAPK7 | 0.66641444 |
| 87 | NEK9 | 0.64988333 |
| 88 | MAP2K6 | 0.64474332 |
| 89 | ABL1 | 0.63556489 |
| 90 | SMG1 | 0.62536792 |
| 91 | STK3 | 0.57771377 |
| 92 | MAPK12 | 0.57666609 |
| 93 | MAPKAPK2 | 0.56750900 |
| 94 | CDK4 | 0.55355961 |
| 95 | EGFR | 0.54354187 |
| 96 | SIK2 | 0.54241956 |
| 97 | RPS6KB2 | 0.53448278 |
| 98 | NLK | 0.52789696 |
| 99 | DYRK1B | 0.51567112 |
| 100 | KDR | 0.51503026 |
| 101 | PRKCQ | 0.51406416 |
| 102 | BRSK2 | 0.51314123 |
| 103 | ITK | 0.50523144 |
| 104 | PRKG2 | 0.48549216 |
| 105 | MAPKAPK3 | 0.47877127 |
| 106 | SIK3 | 0.47097287 |
| 107 | CAMK1D | 0.46860179 |
| 108 | TAOK1 | 0.46570311 |
| 109 | FYN | 0.46437874 |
| 110 | RPS6KA6 | 0.46397952 |
| 111 | CLK1 | 0.45965681 |
| 112 | ICK | 0.45920144 |
| 113 | ABL2 | 0.45715617 |
| 114 | MAP2K2 | 0.41480464 |
| 115 | PRKCD | 0.40932801 |
| 116 | MAP3K7 | 0.40605320 |
| 117 | MAP3K1 | 0.39961648 |
| 118 | MAP3K8 | 0.38531464 |
| 119 | RPS6KA2 | 0.37970508 |
| 120 | RPS6KA1 | 0.36462799 |
| 121 | ALK | 0.36341473 |
| 122 | TESK1 | 0.34834482 |
| 123 | MAPK11 | 0.34830226 |
| 124 | DAPK3 | 0.34616995 |
| 125 | STK24 | 0.33077016 |
| 126 | NEK2 | 0.31614649 |
| 127 | MAPK4 | 0.31573033 |
| 128 | EIF2AK3 | 0.31098479 |
| 129 | RPS6KL1 | 0.29957426 |
| 130 | RPS6KC1 | 0.29957426 |
| 131 | INSR | 0.27536868 |
| 132 | KSR2 | 0.27433616 |
| 133 | YES1 | 0.25689802 |
| 134 | DAPK2 | 0.25009985 |
| 135 | MAP3K6 | 0.23921442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.30572759 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.85938317 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.71970755 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.68912806 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.56003380 |
| 6 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.42379092 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.37865041 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.36133776 |
| 9 | Malaria_Homo sapiens_hsa05144 | 2.22433158 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.15779248 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 2.14793905 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.09424087 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.06409792 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 2.03544676 |
| 15 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.01782993 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.00855489 |
| 17 | Influenza A_Homo sapiens_hsa05164 | 1.94769817 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.84938706 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.83769192 |
| 20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.82221082 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.79272178 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.77255291 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.65085600 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.64659621 |
| 25 | Apoptosis_Homo sapiens_hsa04210 | 1.52767620 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.52543666 |
| 27 | Salmonella infection_Homo sapiens_hsa05132 | 1.50863084 |
| 28 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.47869777 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.46536812 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.44420978 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39134374 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.34252443 |
| 33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.27657645 |
| 34 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.27163382 |
| 35 | Hepatitis C_Homo sapiens_hsa05160 | 1.26362316 |
| 36 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.23714683 |
| 37 | Lysosome_Homo sapiens_hsa04142 | 1.22514953 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.22189899 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.21998586 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.21878181 |
| 41 | Amoebiasis_Homo sapiens_hsa05146 | 1.18735873 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.17820741 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.17567084 |
| 44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.14263121 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.13359959 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.11447437 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07592146 |
| 48 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.06825980 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.02510789 |
| 50 | Phagosome_Homo sapiens_hsa04145 | 1.02368896 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02333676 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00938982 |
| 53 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.88887286 |
| 54 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88397484 |
| 55 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.87374245 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.86495437 |
| 57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.85910943 |
| 58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81546602 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78705556 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77354509 |
| 61 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.76119138 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.74288586 |
| 63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.72634852 |
| 64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.72217309 |
| 65 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.69609713 |
| 66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69131232 |
| 67 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.66403609 |
| 68 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.66273310 |
| 69 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65613619 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64919514 |
| 71 | Platelet activation_Homo sapiens_hsa04611 | 0.64280451 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.64040369 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63943223 |
| 74 | Adherens junction_Homo sapiens_hsa04520 | 0.62752488 |
| 75 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.62714203 |
| 76 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59459521 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58243261 |
| 78 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57876033 |
| 79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53967062 |
| 80 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.51814269 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50915359 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.45180154 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44361945 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43952689 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41698856 |
| 86 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.40427422 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | 0.39018929 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38794833 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37784453 |
| 90 | Focal adhesion_Homo sapiens_hsa04510 | 0.37662873 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37146067 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36477501 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36418339 |
| 94 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.35869105 |
| 95 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35105131 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34063955 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | 0.33511848 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.32898873 |
| 99 | Prostate cancer_Homo sapiens_hsa05215 | 0.32590938 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31044490 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30398188 |
| 102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29168640 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.25097301 |
| 104 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24594485 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23985485 |
| 106 | Pathways in cancer_Homo sapiens_hsa05200 | 0.23883827 |
| 107 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.23316195 |
| 108 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.21135851 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.20428640 |
| 110 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20010132 |
| 111 | ABC transporters_Homo sapiens_hsa02010 | 0.19401126 |
| 112 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.19264645 |
| 113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.18099416 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.17528633 |
| 115 | Lysine degradation_Homo sapiens_hsa00310 | 0.16754005 |
| 116 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.15709158 |
| 117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.14549985 |

